More turbulence at Aurinia as autoimmune drugmaker lays off 45% of workforce

More turbulence at Aurinia as autoimmune drugmaker lays off 45% of workforce

Source: 
Fierce Pharma
snippet: 

After an activist investor revolted against the leadership team at Aurinia Pharmaceuticals, the CEO in question is resorting to restructuring.

Aurinia on Thursday unveiled a strategic overhaul that will slash 45% of the Canadian biotech’s entire workforce.